2‐Amino‐4‐aryl‐5‐oxo‐4,5‐dihydropyrano[3,2‐ c ]chromene‐3‐carbonitriles with Microtubule‐Disruptive, Centrosome‐Declustering, and Antiangiogenic Effects in vitro and in vivo-Reference-Cited by-同舟云学术

2‐Amino‐4‐aryl‐5‐oxo‐4,5‐dihydropyrano[3,2‐ c ]chromene‐3‐carbonitriles with Microtubule‐Disruptive, Centrosome‐Declustering, and Antiangiogenic Effects in vitro and in vivo

Published:2022-03-16 Issue:10 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Köhler Leonhard H. F.¹,Reich Sebastian¹,Begemann Gerrit²^ORCID,Schobert Rainer¹^ORCID,Biersack Bernhard¹^ORCID

Affiliation:

1. Organic Chemistry Laboratory University of Bayreuth Universitätsstraße 30 95447 Bayreuth Germany

2. Department of Biology University of Bayreuth Universitätsstraße 30 95447 Bayreuth Germany

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200064

Reference99 articles.

1. Into the Fray! A Beginner's Guide to Medicinal Chemistry

3. Recent Advances in Solution-PhaseMulticomponent Methodology for the Synthesis of HeterocyclicCompounds

4. Multi-component reactions and evolutionary chemistry

5. Multicomponent Reactions with Isocyanides

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silica-supported Bi2O3Cr2O3 nanocomposite: Efficient catalyst for Pyrano[3,2-c]chromenes synthesis and DFT studies;Journal of Molecular Structure;2025-01

2. Efficient synthesis of dihydropyranochromene derivatives via nanocopper immobilized on Zn/Cr-LDH functionalized with poly(p-phenylenediamine);Journal of Molecular Structure;2024-09

3. Anti‐Tumoural [NHC(thiolato)] Gold(I) Complexes Derived from HIF‐1α Inhibitor AC1‐004 Target the Mitochondrial Redox System and Show Antiangiogenic Effects in vivo;ChemPlusChem;2023-05

4. Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities;Cancer Drug Resistance;2023

5. A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties;ACS Medicinal Chemistry Letters;2022-10-31